Deep molecular response: the new target of treatment of chronic myeloid leukemia?.
10.3760/cma.j.issn.0253-2727.2014.02.027
- Author:
Qian JIANG
1
Author Information
1. Peking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.
- Publication Type:Journal Article
- MeSH:
Cytogenetic Analysis;
Humans;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
drug therapy;
Protein-Tyrosine Kinases;
antagonists & inhibitors
- From:
Chinese Journal of Hematology
2014;35(2):176-179
- CountryChina
- Language:Chinese
